Literature DB >> 14639108

Detection of fusion gene transcripts in fresh-frozen and formalin-fixed paraffin-embedded tissue sections of soft-tissue sarcomas after laser capture microdissection and rt-PCR.

L Jin1, J Majerus, A Oliveira, C Y Inwards, A G Nascimento, L J Burgart, R V Lloyd.   

Abstract

The diagnosis of small round cell sarcomas is often very difficult, especially when only small biopsy specimens are available for examination. Recent studies have shown that some sarcomas have specific recurrent chromosomal translocations producing chimeric gene fusions, which can be detected by reverse transcription-polymerase chain reaction (RT-PCR), fluorescent in situ hybridization (FISH), or cytogenetic analysis. In this study, 12 cases of well-defined sarcomas including Ewings sarcoma/primitive neuroectodermal tumors (ES/PNET), synovial sarcoma (SS), alveolar rhabdomyosarcoma (ARMS), and desmoplastic small round cell tumors (DSRCT) were used to collect specific numbers of cells by laser capture microdissection (LCM), subsequently used for RT-PCR to detect specific chimeric gene transcripts. Tumor cells from fresh-frozen (FS) tissue sections and paraffin-embedded (PS) tissue sections from the same cases were compared directly to evaluate the sensitivity of FS and PS sections as the starting material for analysis. Samples were used for RNA extraction, RT-PCR analysis, and Southern hybridization with fluorescein-labeled internal probes followed by enhance chemiluminescence (ECL) detection. The fusion gene transcripts could be detected using 50 cells from FS materials in all cases and from 1 cell in 9 of 12 cases. For PS, a positive signal could be detected using 200 to 1000 cells in all cases, while weaker signals were detected using 50 cells in most cases. These results indicate that the fusion gene products from small round cell sarcomas can be detected by RT-PCR with 10 to 200 cells from FS and PS tissues. The sensitivity of RT-PCR with FS was 10- to 50-fold greater than with PS. These results also suggest that RT-PCR analysis for sarcoma fusion gene products can be successfully performed when only a few cells are available for analysis, although this is not recommended for routine clinical use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639108     DOI: 10.1097/00019606-200312000-00006

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  11 in total

1.  Synovial sarcoma presenting as an avascular mass: radiologic-pathologic correlation.

Authors:  Ann E McCullough; Adam J Schwartz; Veronica L Taylor; Mark J Kransdorf
Journal:  Skeletal Radiol       Date:  2014-08-01       Impact factor: 2.199

Review 2.  Biphasic malignant tumours of the abdominal cavity.

Authors:  L Max Almond; Adrian T Warfield; Anant Desai; David Gourevitch; Samuel J Ford
Journal:  Int J Clin Oncol       Date:  2017-06-27       Impact factor: 3.402

3.  Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.

Authors:  Kenichi Kohashi; Yoshinao Oda; Hidetaka Yamamoto; Sadafumi Tamiya; Tomonari Takahira; Yukiko Takahashi; Tatsuro Tajiri; Tomoaki Taguchi; Sachiyo Suita; Masazumi Tsuneyoshi
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

4.  Micro RNA detection in long-term fixed tissue of cortical glutamatergic pyramidal neurons after targeted laser-capture neuroanatomical microdissection.

Authors:  Roberto R Herai; Lisa Stefanacci; Branka Hrvoj-Mihic; Thanathom Chailangkarn; Kari Hanson; Katerina Semendeferi; Alysson R Muotri
Journal:  J Neurosci Methods       Date:  2014-06-30       Impact factor: 2.390

5.  Synovial sarcoma of the sellar region.

Authors:  Bernd W Scheithauer; Ana Isabel Silva; Keith Kattner; Jason Seibly; Andre M Oliveira; Kalman Kovacs
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

Review 6.  [The use of frozen sections in the handling of soft tissue tumors].

Authors:  G Amann; B Liegl-Atzwanger
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

7.  FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.

Authors:  Masaaki Kuda; Kenichi Kohashi; Yuichi Yamada; Akira Maekawa; Yoshiaki Kinoshita; Tetsuya Nakatsura; Yukihide Iwamoto; Tomoaki Taguchi; Yoshinao Oda
Journal:  Tumour Biol       Date:  2015-11-09

Review 8.  Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).

Authors:  Margherita Cerrone; Monica Cantile; Francesca Collina; Laura Marra; Giuseppina Liguori; Renato Franco; Annarosaria De Chiara; Gerardo Botti
Journal:  Int J Mol Med       Date:  2014-04-04       Impact factor: 4.101

9.  Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.

Authors:  Akira Maekawa; Kenichi Kohashi; Masaaki Kuda; Kunio Iura; Takeaki Ishii; Makoto Endo; Tetsuya Nakatsura; Yukihide Iwamoto; Yoshinao Oda
Journal:  BMC Cancer       Date:  2016-07-20       Impact factor: 4.430

10.  The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

Authors:  Jonathan Noujaim; Robin L Jones; John Swansbury; David Gonzalez; Charlotte Benson; Ian Judson; Cyril Fisher; Khin Thway
Journal:  Br J Cancer       Date:  2017-01-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.